GABAeron, Inc.
Rebuilding Neurons, Restoring Lives
San Francisco, United States · Founded 2018 · $1.8M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2G
- Website
- gabaeron.com
- Total Funding
- $1.8M
- Last Round
- $1.1M GrantJan 2021
- Rounds
- 4
About
GABAeron is a San Francisco-based biopharmaceutical company developing iPSC-derived GABAergic interneuron cell therapies and small molecules to treat apoE4-linked neurodegenerative diseases, including Alzheimer's disease. The company combines precision medicine with regenerative medicine, targeting hippocampal neuron replacement as a first-in-class IND candidate.
Summary
GABAeron, Inc. is a Biotech company based in San Francisco, United States, founded in 2018. It has raised $1.8M in total across 4 rounds, most recently a $1.1M Grant round in Jan 2021.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Sign up to see all 4 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gabaeron-inc"><img src="https://indexed.vc/api/badge/company/gabaeron-inc" alt="GABAeron, Inc. on Indexed.vc" width="260" height="76" /></a>